Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Alternative Health Distribution is a U.S.-based commercial-stage cannabinoid products company focused on wholesale hemp-derived products, formulation, manufacturing, and distribution. The company markets itself as a leading national distributor of bulk cannabinoid products including CBD, Delta 8, THCA, HHC, and related blends, serving retailers and distributors. It also appears to operate or support in-house and partner brands, including Rizzy in hemp beverages, and has expanded into beverage-focused commercialization through the LYNC Bev joint venture with Give Back Wine Group. The business is oriented toward compliant manufacturing, supply chain execution, and large-scale wholesale fulfillment rather than traditional prescription drug R&D. For a biotech or pharma analyst, this is best classified as a commercial cannabinoid wellness and distribution company rather than a drug-development biotech.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Alternative Health Distribution.